PATENT CLAIM ANALYSIS

Application Number: 15865647
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "006120"]

Abstract:
The technology described herein is directed to the treatment of cancer, e.g. methods and assays relating to selecting and administering a chemotherapy with or without an EZH2 inhibitor.

Claim (Index 20):
The method of  claim 11 , further comprising the step of generating a report based on the detection of a sensitizing mutation in BRG1, EGFR, or B-RAF by a non-human machine.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.10714
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14650473', '14346359', '14777211', '14443602', '15803478']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5821049995524804
- 35 USC 102 Novelty (BERT): 0.713906107710974
- Combined Prediction Score: 0.5952851103683298
- Mean Citation Score: 377.43235
- Max Citation Score: 794.9364
- Similarity Product: 757.0233922667027

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test